Literature DB >> 20521138

Feasibility of an accurate assessment of myocardial salvage by comparing functional and perfusion abnormalities in post-reperfusion gated SPECT.

Roberto Sciagrà1, Manjola Dona, Angela Coppola, Mario Leoncini, Mauro Maioli, Antonio Castagnoli, Francesco Bellandi, Alberto Pupi.   

Abstract

BACKGROUND: Because of persistent stunning, post-treatment functional abnormalities could identify the initial risk area. The study aims to detect myocardial salvage using post-revascularization gated SPECT in acute myocardial infarction (AMI) treated by reperfusion therapy.
METHODS: In 36 AMI patients, we performed a first gated SPECT injecting (99m)Tc-sestamibi before primary percutaneous coronary intervention (PCI), and a second 5 days later. The salvage index defined by the two perfusion images was compared with the value obtained by subtracting in the second gated SPECT the extent of perfusion defect from the extent of wall thickening abnormalities.
RESULTS: The wall thickening salvage index correlated with the reference perfusion salvage index (Spearman's ρ = .92, P < .0001), with a 95% limit of agreement = ±.25. The agreement between the classifications in salvage index tertiles of the reference and of the wall thickening salvage index was good (kappa = .75). All patients with optimal PCI result and 18/24 of those with intermediate or poor outcome were correctly classified.
CONCLUSIONS: Comparing function and perfusion in a single post-PCI (99m)Tc-sestamibi gated SPECT it is possible to estimate myocardial salvage. This could have useful implications in studies comparing different treatment strategies for AMI.

Entities:  

Mesh:

Year:  2010        PMID: 20521138     DOI: 10.1007/s12350-010-9247-x

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  25 in total

Review 1.  Infarct size measured by single photon emission computed tomographic imaging with (99m)Tc-sestamibi: A measure of the efficacy of therapy in acute myocardial infarction.

Authors:  R J Gibbons; T D Miller; T F Christian
Journal:  Circulation       Date:  2000 Jan 4-11       Impact factor: 29.690

2.  Full-motion pulse inversion power Doppler contrast echocardiography differentiates stunning from necrosis and predicts recovery of left ventricular function after acute myocardial infarction.

Authors:  M L Main; A Magalski; N K Chee; M M Coen; D G Skolnick; T H Good
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

3.  Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators.

Authors:  A Schömig; A Kastrati; J Dirschinger; J Mehilli; U Schricke; J Pache; S Martinoff; F J Neumann; M Schwaiger
Journal:  N Engl J Med       Date:  2000-08-10       Impact factor: 91.245

4.  Estimate of myocardial salvage in late presentation acute myocardial infarction by comparing functional and perfusion abnormalities in predischarge gated SPECT.

Authors:  Barbara Sotgia; Roberto Sciagrà; Guido Parodi; Adnan Kastrati; David Antoniucci; Albert Schömig; Alberto Pupi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-11       Impact factor: 9.236

5.  Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction.

Authors:  R J Gibbons; M S Verani; T Behrenbeck; P A Pellikka; M K O'Connor; J J Mahmarian; J H Chesebro; F J Wackers
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

6.  Single photon emission computed tomography with technetium-99m hexakis 2-methoxyisobutyl isonitrile in acute myocardial infarction before and after thrombolytic treatment: assessment of salvaged myocardium and prediction of late functional recovery.

Authors:  G M Santoro; G Bisi; R Sciagrà; M Leoncini; P F Fazzini; U Meldolesi
Journal:  J Am Coll Cardiol       Date:  1990-02       Impact factor: 24.094

7.  Ability of mechanical reperfusion to salvage myocardium in patients with acute myocardial infarction presenting beyond 12 hours after onset of symptoms.

Authors:  Guido Parodi; Gjin Ndrepepa; Adnan Kastrati; Alberto Conti; Julinda Mehilli; Roberto Sciagrà; Markus Schwaiger; David Antoniucci; Albert Schømig
Journal:  Am Heart J       Date:  2006-12       Impact factor: 4.749

8.  Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h.

Authors:  Martin Busk; Anne Kaltoft; Søren S Nielsen; Morten Bøttcher; Michael Rehling; Leif Thuesen; Hans E Bøtker; Jens F Lassen; Evald H Christiansen; Lars R Krusell; Henning R Andersen; Torsten T Nielsen; Steen D Kristensen
Journal:  Eur Heart J       Date:  2009-04-08       Impact factor: 29.983

9.  Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group.

Authors:  A W van 't Hof; A Liem; H Suryapranata; J C Hoorntje; M J de Boer; F Zijlstra
Journal:  Circulation       Date:  1998-06-16       Impact factor: 29.690

Review 10.  The stunned myocardium: prolonged, postischemic ventricular dysfunction.

Authors:  E Braunwald; R A Kloner
Journal:  Circulation       Date:  1982-12       Impact factor: 29.690

View more
  2 in total

1.  Measuring myocardium at risk in acute myocardial infarction--a continuing challenge.

Authors:  Todd D Miller; Raymond J Gibbons
Journal:  J Nucl Cardiol       Date:  2010-10       Impact factor: 5.952

2.  Prediction of functional recovery after primary PCI using the estimate of myocardial salvage in gated SPECT early after acute myocardial infarction.

Authors:  Raffaella Calabretta; Angelo Castello; Flavia Linguanti; Francesca Tutino; Alfonso Ciaccio; Cristina Giglioli; Roberto Sciagrà
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-01       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.